Department head: Therese Sørlie
Department deputy head (adm): Gry Aarum Geitvik
Department secretary: Mona Hagen

Vision: Towards personalized therapy for cancer; integrated molecular and epidemiological studies to reduce risk, achieve early diagnosis, improve prognosis, and tailor the treatment for breast, lung, pancreatic and ovarian cancer.

Our aim is to improve risk estimation, achieve earlier diagnosis and improve prediction of treatment responses and other clinical outcomes for patients with early and advanced stages of both solid tumors and hematologic malignancies. Our research is translational in nature and include functional studies, molecular classification, data integration and pan-cancer analyses. We work towards facilitating the implementation of discoveries into clinical use. A common theme across groups is to achieve a deeper molecular understanding of inter- and intra-tumor heterogeneity and tumor evolution using patient cohorts and mouse models.

Watch video presenting our department

Lab technology group, headed by Gry Aarum Geitvik

	Goals: Using the best methods available to answer the scientific questions asked Generate and maintain the biobank and data bases Generate laboratory results of excellent quality Highly educated and competent personnel that is up to date with recent innovations in laboratory methodology/technology
	Visit homepage

Contact information:

Department of Cancer Genetics, Institute for Cancer Research
The Norwegian Radium Hospital, N-0310 Oslo, Norway
Phone: +47 2278 1374, Fax: +47 2278 1395, Switchboard: +47 915 02770

2011 - 2016

https://www.ous-research.no/kgjebsen/